Bio-Rad Laboratories, Qiagen Mull Merger Of Equals
Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all.
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 528 companies set new 52-week lows.
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…
Neuron23 and QIAGEN Announced Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug; Terms Not Disclosed
Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases, and QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a collaboration to develop a companion diagnostic for Neuron23's LRRK2 inhibitor for Parkinson's disease.
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
QIAGEN Highlights Launch
https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2022/QIAGEN-launches-new-solutions-that-significantly-accelerate-DNA-variant-detection-and-RNA-sequencing-of-low-input-samples/default.as
QIAGEN Reports Purchase Of Majority Stake In BLIRT, No Terms Disclosed
BLIRT adds new R&D and manufacturing capabilities for customized and standardized recombinant enzymes, as well as molecular biology reagents
Strengthens QIAGEN’s sample technologies business, one of the
Natera Clocks 28% Jump In Q1 Sales, Lifts FY22 Guidance
Natera Inc (NASDAQ:NTRA) generated Q1 revenues of $194.1 million, up 27.5% Y/Y, beating the consensus of $176.60 million. Product revenues…
QIAGEN Continues To Update Its Range Of Automation Solutions With The Launch Of High-sensitive Capillary Electrophoresis Instrument Qiaxcel Connect
Qiagen N.V. - QIAGEN continues to update its range of automation solutions with the launch of high-sensitive capillary electrophoresis instrument QIAxcel Connect